In lung cancer, PRMT5 has been reported to regulate the HIF1 signaling pathway, but its direct roles in aerobic glycolysis under the control of the HIF1 signaling pathway have seldom been reported [50, 51]. Here, PRMT5 is linked to lung carcinoma.